Literature DB >> 3405254

Changes in pulmonary mechanics after the administration of surfactant to infants with respiratory distress syndrome.

J M Davis1, K Veness-Meehan, R H Notter, V K Bhutani, J W Kendig, D L Shapiro.   

Abstract

We assessed pulmonary mechanics in 35 premature infants with respiratory distress syndrome just before and one hour after the administration of 90 mg of surfactant to each infant. Transpulmonary pressure was measured between the airway opening and an esophageal balloon with use of a differential transducer, and flow rates were measured by a pneumotachometer. Values for pulmonary mechanics were then calculated by microcomputer processing. The administration of surfactant produced a large decrease (56 percent) in the mean (+/- SEM) ratio of alveolar to arterial oxygen, from 7.1 +/- 0.5 to 3.1 +/- 0.2 (P less than 0.0001)--a change that indicates improvement in gas exchange. Associated changes in pulmonary mechanics were not demonstrable when 10 of the infants were studied during continuous mechanical ventilation. However, in the 25 infants examined during spontaneous breathing with continuous positive airway pressures (identical airway pressures before and after treatment), large and consistent improvements in pulmonary mechanics were found after the administration of surfactant. Tidal volume increased by 32 percent (P less than 0.03), minute ventilation by 38 percent (P less than 0.02), dynamic compliance by 29 percent (P less than 0.004), and inspiratory flow rates by 54 percent (P less than 0.01). We conclude that significant improvement in pulmonary mechanics results from surfactant-replacement therapy for respiratory distress syndrome, but that these mechanical changes are apparent only during spontaneous respiration and can be masked if measurements are made during mechanical ventilation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3405254     DOI: 10.1056/NEJM198808253190804

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  14 in total

Review 1.  Long term sequelae of bronchopulmonary dysplasia (chronic lung disease of infancy).

Authors:  E Eber; M S Zach
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

Review 2.  Calfactant: a review of its use in neonatal respiratory distress syndrome.

Authors:  S V Onrust; M Dooley; K L Goa
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

3.  Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Collaborative European Multicentre Study Group.

Authors: 
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

4.  Respiratory compliance in premature babies treated with artificial surfactant (ALEC).

Authors:  C J Morley; A Greenough
Journal:  Arch Dis Child       Date:  1991-04       Impact factor: 3.791

Review 5.  Exogenous surfactant treatments for neonatal respiratory distress syndrome and their potential role in the adult respiratory distress syndrome.

Authors:  T A Merritt; M Hallman; R Spragg; G P Heldt; N Gilliard
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

6.  Evaluation of a computerized system for mechanical ventilation of infants.

Authors:  Fleur T Tehrani; Soraya Abbasi
Journal:  J Clin Monit Comput       Date:  2009-03-05       Impact factor: 2.502

7.  How does exogenous surfactant work?

Authors:  A D Milner
Journal:  Arch Dis Child       Date:  1993-03       Impact factor: 3.791

8.  Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.

Authors:  B J Stenson; R M Glover; G J Parry; R A Wilkie; I A Laing; W O Tarnow-Mordi
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747

Review 9.  Lung function testing--useless in ventilated newborns?

Authors:  O Hjalmarson
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

10.  Early changes in lung function and response to surfactant replacement therapy.

Authors:  A T Gibson; R A Primhak
Journal:  Eur J Pediatr       Date:  1994-07       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.